<DOC>
	<DOCNO>NCT00337610</DOCNO>
	<brief_summary>A clinical study determine safety efficacy sitagliptin patient Type 2 Diabetes Mellitus inadequate glycemic ( blood sugar ) control metformin therapy .</brief_summary>
	<brief_title>Sitagliptin Metformin Add-on Study Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient type 2 diabetes mellitus Males Females highly unlikely become pregnant Patients poorly control take one two oral antidiabetic medication Patient history type 1 diabetes mellitus history ketoacidosis Patient require insulin therapy within prior 8 week Patient take Thiazolidinediones ( TZDs ) Actos® ( pioglitazone ) Avandia® ( rosiglitazone ) take Byetta® ( exenatide ) within prior 12 week screen visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>